rs374054249

Variant summary

Our verdict is Benign. The variant received -18 ACMG points: 0P and 18B. BP4_ModerateBP6_Very_StrongBS1BS2

The ENST00000379989.6(CDKL5):​c.2941C>G​(p.Arg981Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000644 in 1,210,840 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 28 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R981Q) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.000035 ( 0 hom., 1 hem., cov: 24)
Exomes 𝑓: 0.000067 ( 0 hom. 27 hem. )

Consequence

CDKL5
ENST00000379989.6 missense

Scores

2
14

Clinical Significance

Benign reviewed by expert panel U:1B:4

Conservation

PhyloP100: -0.0770

Publications

1 publications found
Variant links:
Genes affected
CDKL5 (HGNC:11411): (cyclin dependent kinase like 5) This gene is a member of Ser/Thr protein kinase family and encodes a phosphorylated protein with protein kinase activity. Mutations in this gene have been associated with X-linked infantile spasm syndrome (ISSX), also known as X-linked West syndrome, and Rett syndrome (RTT). Alternate transcriptional splice variants have been characterized. [provided by RefSeq, Jul 2008]
RS1 (HGNC:10457): (retinoschisin 1) This gene encodes an extracellular protein that plays a crucial role in the cellular organization of the retina. The encoded protein is assembled and secreted from photoreceptors and bipolar cells as a homo-oligomeric protein complex. Mutations in this gene are responsible for X-linked retinoschisis, a common, early-onset macular degeneration in males that results in a splitting of the inner layers of the retina and severe loss in vision. [provided by RefSeq, Oct 2008]
RS1 Gene-Disease associations (from GenCC):
  • retinoschisis
    Inheritance: XL Classification: DEFINITIVE Submitted by: G2P
  • X-linked retinoschisis
    Inheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet, Labcorp Genetics (formerly Invitae), Myriad Women’s Health, ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -18 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.139783).
BP6
Variant X-18650553-C-G is Benign according to our data. Variant chrX-18650553-C-G is described in ClinVar as Benign. ClinVar VariationId is 512938.Status of the report is reviewed_by_expert_panel, 3 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0000355 (4/112685) while in subpopulation NFE AF = 0.000075 (4/53321). AF 95% confidence interval is 0.0000255. There are 0 homozygotes in GnomAd4. There are 1 alleles in the male GnomAd4 subpopulation. Median coverage is 24. This position passed quality control check.
BS2
High AC in GnomAdExome4 at 74 XL,AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
RS1NM_000330.4 linkc.185-3221G>C intron_variant Intron 3 of 5 ENST00000379984.4 NP_000321.1 O15537
CDKL5NM_001037343.2 linkc.2941C>G p.Arg981Gly missense_variant Exon 21 of 22 NP_001032420.1 O76039-1
CDKL5NM_003159.3 linkc.2941C>G p.Arg981Gly missense_variant Exon 20 of 21 NP_003150.1 O76039-1
RS1XM_047442337.1 linkc.-170G>C 5_prime_UTR_variant Exon 1 of 4 XP_047298293.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
RS1ENST00000379984.4 linkc.185-3221G>C intron_variant Intron 3 of 5 1 NM_000330.4 ENSP00000369320.3 O15537

Frequencies

GnomAD3 genomes
AF:
0.0000355
AC:
4
AN:
112685
Hom.:
0
Cov.:
24
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000750
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000109
AC:
2
AN:
183367
AF XY:
0.00
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000244
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000674
AC:
74
AN:
1098155
Hom.:
0
Cov.:
30
AF XY:
0.0000743
AC XY:
27
AN XY:
363509
show subpopulations
African (AFR)
AF:
0.0000379
AC:
1
AN:
26403
American (AMR)
AF:
0.00
AC:
0
AN:
35207
Ashkenazi Jewish (ASJ)
AF:
0.0000516
AC:
1
AN:
19386
East Asian (EAS)
AF:
0.00
AC:
0
AN:
30206
South Asian (SAS)
AF:
0.00
AC:
0
AN:
54146
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
40508
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4137
European-Non Finnish (NFE)
AF:
0.0000843
AC:
71
AN:
842068
Other (OTH)
AF:
0.0000217
AC:
1
AN:
46094
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.470
Heterozygous variant carriers
0
3
6
8
11
14
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000355
AC:
4
AN:
112685
Hom.:
0
Cov.:
24
AF XY:
0.0000287
AC XY:
1
AN XY:
34831
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
31004
American (AMR)
AF:
0.00
AC:
0
AN:
10686
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2654
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3592
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2741
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
6238
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
239
European-Non Finnish (NFE)
AF:
0.0000750
AC:
4
AN:
53321
Other (OTH)
AF:
0.00
AC:
0
AN:
1520
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.558
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.0000453
TwinsUK
AF:
0.00
AC:
0
ALSPAC
AF:
0.000346
AC:
1
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000149
AC:
1
EpiCase
AF:
0.00
EpiControl
AF:
0.0000593

ClinVar

Significance: Benign
Submissions summary: Uncertain:1Benign:4
Revision: reviewed by expert panel
LINK: link

Submissions by phenotype

not provided Benign:2
Dec 20, 2018
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 01, 2023
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

CDKL5: BP4 -

Developmental and epileptic encephalopathy, 2 Uncertain:1
Nov 05, 2021
Revvity Omics, Revvity
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

CDKL5 disorder Benign:1
Jun 25, 2025
ClinGen Rett and Angelman-like Disorders Variant Curation Expert Panel
Significance:Benign
Review Status:reviewed by expert panel
Collection Method:curation

The highest population minor allele frequency of the p.Arg981Gly variant in CDKL5 (NM_003159.2) in gnomAD v4.1 is 0.00008376 in the Non-Finnish European population, which is higher than the ClinGen Rett and Angelman-like Disorders VCEP threshold (≥0.00008) for BS1, and therefore meets this criterion (BS1). The p.Arg981Gly variant is observed in at least 2 unaffected individuals (internal database - GeneDx) (BS2). The p.Arg981Gly variant is found in at least 3 patients with an alternate molecular basis of disease (internal database - GeneDx) (BP5_strong). The computational predictor REVEL gives a score of 0.078, which is below the threshold of 0.290, evidence that does not predict a damaging effect on CDKL5 function (BP4). RS1 (NM_000330.4) and an alternative transcript of CDKL5 (NM_003159.2) are overlapping transcripts; however, these variants are in the noncoding 3' region of the main CDKL5 transcript (NM_001323289.2). The c.2941C>G (p.Arg981Gly) variant in CDKL5 transcript (NM_003159.2) (NM_000330.4 (RS1):c.185-3221G>C) is classified as benign based on the ACMG/AMP criteria (BS1, BS2, BP5_strong, BP4). (CDKL5 Specifications v.4.1; curation approved on 06/25/2025) -

Developmental and epileptic encephalopathy, 2;CN128785:Angelman syndrome-like Benign:1
Jun 04, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Benign
-0.31
T
BayesDel_noAF
Benign
-0.62
CADD
Benign
1.9
DANN
Benign
0.96
DEOGEN2
Benign
0.029
T;T
FATHMM_MKL
Benign
0.020
N
LIST_S2
Benign
0.46
.;T
M_CAP
Pathogenic
0.89
D
MetaRNN
Benign
0.14
T;T
MetaSVM
Benign
-0.96
T
MutationAssessor
Benign
0.0
N;N
PhyloP100
-0.077
PrimateAI
Benign
0.27
T
PROVEAN
Benign
-0.17
N;N
REVEL
Benign
0.078
Sift
Benign
0.037
D;D
Sift4G
Pathogenic
0.0
D;D
Polyphen
0.0020
B;B
Vest4
0.23
MVP
0.34
MPC
0.62
ClinPred
0.048
T
GERP RS
-1.3
Varity_R
0.089
gMVP
0.16
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs374054249; hg19: chrX-18668673; API